Clinical and nutritional evolution of patients undergoing bariatric surgery in a reference hospital in the state of Pernambuco.

Authors

  • LUANA GOMES DA SILVA Instituto de Medicina Integral prof. Fernando Figueira – IMIP
  • CAMILLA ARAÚJO DE BRITO Instituto de Medicina Integral prof. Fernando Figueira – IMIP
  • MARÍLIA TOKIKO OLIVEIRA TOMIYA Universidade Católica de Pernambuco
  • DANIELLA CLAUDIA DE FRANÇA CAVALCANTI Instituto de Medicina Integral prof. Fernando Figueira - IMIP
  • ANA CLARA LACERDA CERVANTES DE CARVALHO Instituto de Medicina Integral prof. Fernando Figueira – IMIP
  • ANDERSON LIBERATO DE SOUZA Instituto de Medicina Integral prof. Fernando Figueira – IMIP
  • SHAIANE CAETANO CHAGAS Instituto de Medicina Integral prof. Fernando Figueira – IMIP
  • LUANA CARLA LACERDA DA CRUZ Instituto de Medicina Integral prof. Fernando Figueira – IMIP

DOI:

https://doi.org/10.12873/441gomes

Keywords:

Bariatric Surgery, Comorbidity, Obesity, Weight loss

Abstract

Obesity is a risk factor for chronic non-communicable diseases such as Type 2 Diabetes Mellitus, Systemic Arterial Hypertension, dyslipidemia, among others. Gastroplasty is among the therapeutic alternatives with a good response on weight loss when physical exercise and diet were not efficient, resulting in better clinical control of associated comorbidities. Therefore, to analyze the clinical and nutritional evolution of patients undergoing bariatric surgery in a referral hospital in the state of Pernambuco, 12 months after the procedure, in order to observe the impacts of this therapy. A series of cases was carried out, which included individuals who underwent bariatric surgery and who had some comorbidity associated with excess weight. Data collection was performed at the nutrition clinic of Instituto de Medicina Integral Prof. Fernando Figueira – IMIP, in the city of Recife-Pernambuco, from May 2021 to October 2021. Anthropometric, clinical and biochemical data were obtained. Forty individuals with a mean age of 43 ± 11.7 years were included in the study, with a predominance of females (92.5%), and the most common surgical technique was the Gastric Bypass (77.5%). A reduction in Glycated Hemoglobin was observed from 5.8% ± 0.5 preoperatively to 5.1% ± 0.2 at 12 months (p = <0.001), and a reduction in Total Cholesterol of 199.0mg/dL for 167.0mg/dL (p = <0.001) before and 12 months after gastroplasty, respectively. In addition to these, we observed a statistically significant improvement in all anthropometric and biochemical variables analyzed, except for fasting blood glucose. Such results can be explained from the alterations in the secretion of intestinal hormones, which help in better glucose, lipid and pressure control, in addition to weight loss. In addition to food reeducation and caloric restriction provided by nutritional monitoring and surgical intervention. Therefore, bariatric surgery seems to have a positive impact on the biochemical and anthropometric evolution.

References

Abeso VI Diretrizes Brasileiras de Obesidade. ABESO - Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica 2016; (4): 7–186.

Apovian CM. Obesity: definition, comorbidities, causes, and burden. The American journal of managed care 2016;22 (7):176–185.

Vigitel Brasil 2018: Vigilância de fatores de risco e proteção para doenças crônicas por inquerito telefônico 2019; 5: 10-50.

OMS. World health statistics 2020: monitoring health for the SDGs, sustainable development goals 2020;25 (07): 1–77.

Castanha CR. et al. Avaliação da qualidade de vida, perda de peso e comorbidades de pacientes submetidos à cirurgia bariátrica. Revista do Colegio Brasileiro de Cirurgioes 2018; 45 (3):1–9.

Welbourn R. et al. Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth IFSO Global Registry Report 2018. Obesity Surgery 2019; 29 (8):782–795.

Yeung Y, Tadi, P. Fisiologia, obesidade, apetite neuro-hormonal e controle da saciedade. STATPEARLS 2021; 15 (6): 1–15.

Ferreira APS, Szwarcwald CL, Damacena GN. Prevalência e fatores associados da obesidade na população brasileira: estudo com dados aferidos da Pesquisa Nacional de Saúde, 2013. Revista brasileira de epidemiologia 2019; 22 (8):1–14.

Angrisani L. et al. Bariatric Surgery Survey 2018: Similarities and Disparities Among the 5 IFSO Chapters. Obesity Surgery 2021; 31 (1):1–12.

Bray GA. et al. Management of obesity. The Lancet 2016; 38 (7): 1947–1956.

O’brien PE. et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding. Obesity Surgery 2019; 29 (1): 3–14.

Lipschitz DA. Screening for nutritional status in the elderly. Primary Care 1994; 21 (1):55–67.

Gadde KM. et al. Obesity: Pathophysiology and Management. Journal of the American College of Cardiology 2018; 71 (1): 69–84.

Faludi AA. et al. Atualização Da Diretriz Brasileira De Dislipidemias E Prevenção Da Aterosclerose - 2017. Arquivos Brasileiros de Cardiologia 2017; 109 (1):1–92.

Alomar AO. et al. The Effect of Bariatric Surgery on Metabolic Syndrome: A Three-center Experience in Saudi Arabia. Obesity Surgery 2021; 31 (8): 3630–3636.

Fakhry TK. et al. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis. Surgery for Obesity and Related Diseases 2019; 15 (3): 502–511.

Rech AC, Matsumoto HM. Remissão de hipertensão arterial sistêmica, Diabetes mellitus tipo II e dislipidemia após cirurgia bariátrica: um estudo longitudinal. Research, Society and Development 2021; 10 (12).

Vigilante A. et al. Impact on Dyslipidemia After Laparoscopic Sleeve Gastrectomy. Obesity Surgery 2018; 28 (10): 3111–3115.

Guerreiro VB. et al. Long-Term weight loss and metabolic syndrome remission after bariatric surgery: The effect of sex, age, metabolic parameters and surgical technique-a 4-year follow-up study. Obesity Facts 2019; 12 (6):639–652.

Diemieszczyk I. et al. Does weight loss after laparoscopic sleeve gastrectomy contribute to reduction in blood pressure? Polish Archives of Internal Medicine, 2021;131 (7–8): 693–700.

Ji Y. et al. Effect of bariatric surgery on metabolic diseases and underlying mechanisms. Biomolecules 2021;11 (11): 1–14.

Wang Y. et al. Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy for Super Super Obese and Super Obese: Systematic Review and Meta-analysis of Weight Results, Comorbidity Resolution. Obesity Surgery 2019; 29 (6): 1954–1964.

Pucci A, Batterham RL. Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different. Journal of Endocrinological Investigation 2019; 42 (2):117–128.

Xu GC, Song, M. Recent advances in the mechanisms underlying the beneficial effects of bariatric and metabolic surgery. Surgery for Obesity and Related Diseases 2021; 17 (1): 231–238.

Bhupathiraju SN, Hu FB. Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications. Circulation research 2016; 118 (11): 1723–1735.

Published

2024-01-02

How to Cite

GOMES DA SILVA, L., ARAÚJO DE BRITO, C., TOKIKO OLIVEIRA TOMIYA, M., CLAUDIA DE FRANÇA CAVALCANTI, D., LACERDA CERVANTES DE CARVALHO, A. C., LIBERATO DE SOUZA, A., … LACERDA DA CRUZ, L. C. (2024). Clinical and nutritional evolution of patients undergoing bariatric surgery in a reference hospital in the state of Pernambuco. Nutrición Clínica Y Dietética Hospitalaria, 44(1). https://doi.org/10.12873/441gomes

Issue

Section

Research articles

Categories

Most read articles by the same author(s)